Back
Hewlett Packard Enterprise Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
46
HPE
Hewlett Packard Enterprise
Last Price:
20.92
Seasonality Move:
1.35%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
39.58
Seasonality Move:
3.65%
Sell
46
Hewlett Packard Enterprise (HPE)
is a Sell
Is Hewlett Packard Enterprise a Buy, Sell or Hold?
- The current Hewlett Packard Enterprise [HPE] share price is $20.92. The Score for HPE is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- HPE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HPE Stock Price Chart
What is Hewlett Packard Enterprise's stock price today?
-
The Hewlett Packard Enterprise share price today is $20.92
The current trend is moderately bullish and HPE is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
HPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.02 | Buy |
| Relative Strength Index (14 RSI): | 63.9 | Buy |
| Chaikin Money Flow: | 1881660 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.85 - 20.93) | Buy |
| Bollinger Bands (100): | (15.73 - 19.09) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.73 | Sell |
| Relative Strength Index (14 RSI): | 45.77 | Sell |
| Chaikin Money Flow: | 722527 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.99 - 42.29) | Sell |
| Bollinger Bands (100): | (41.03 - 48.83) | Sell |
HPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.34 | Sell |
| 20-day SMA: | 19.77 | Buy |
| 50-day SMA: | 18.25 | Buy |
| 200-day SMA: | 16.91 | Buy |
| 8-day EMA: | 21.09 | Sell |
| 20-day EMA: | 20.09 | Buy |
| 50-day EMA: | 18.8 | Buy |
| 200-day EMA: | 17.21 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.38 | Sell |
| 20-day SMA: | 40.41 | Sell |
| 50-day SMA: | 41.94 | Sell |
| 200-day SMA: | 42.46 | Sell |
| 8-day EMA: | 39.76 | Sell |
| 20-day EMA: | 40.54 | Sell |
| 50-day EMA: | 42.03 | Sell |
| 200-day EMA: | 43.46 | Sell |
Hewlett Packard Enterprise Earnings Growth & HPE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.22 per share, and an increase next year of $0.19 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
Hewlett Packard Enterprise Technical Analysis
| Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||